1. Dry Eye
  2. Rexon-Eye® | A New Era in Dry Eye Therapy
Video file

Rexon-Eye® | A New Era in Dry Eye Therapy

Treat the Cause — Not Just the Symptoms

Rexon-Eye® is a non-invasive, clinically validated therapy for dry eye disease that goes beyond temporary relief. Using patented Quantum Molecular Resonance (QMR®) Technology, Rexon-Eye® stimulates the natural regeneration of ocular tissues and reduces inflammation — offering long-lasting results for all forms of dry eye.

REQUEST INFO

Call our expert team today on 01527 501077

Further Information

Why Choose Rexon-Eye®?

  • Targets the root cause of dry eye – not just symptoms
  • Effective for all types of dry eye: evaporative, aqueous-deficient, and mixed
  • Anti-inflammatory effect – disrupts the vicious circle of chronic dry eye
  • Regenerative action – promotes cell metabolism and healing
  • Comfortable and relaxing – suitable for all skin types
  • Hands-free sessions – clinician sets up, patient relaxes
  • Clinically proven – backed by peer-reviewed publications

How It Works

Rexon-Eye® delivers a mild electrical current across a range of frequencies (4–64 MHz) via a specially designed mask. This gentle stimulation triggers:

  • Anti-inflammatory cytokine release by shifting macrophage activity
  • Activation of mesenchymal stem cells (MSCs) to regenerate damaged tissue
  • Restoration of the tear film and ocular surface balance

Each treatment is 20 minutes long, carried out once a week for four weeks. The therapy is painless, soothing, and allows patients to pause at any time using a Patient Calm Control.

Who Can Benefit?

Rexon-Eye® is ideal for patients experiencing:

  • Chronic dryness, burning, or gritty eyes
  • Blurred vision or difficulty reading
  • Contact lens discomfort
  • Post-operative ocular surface stress
  • Autoimmune-related dry eye (e.g., Sjögren’s syndrome)
  • Hormonal or age-related ocular changes

Accessories & Portability

To enhance hygiene, safety, and ease of use, Rexon-Eye® is supported by:

  • Personalised single-use therapy pads
  • Disposable waterproof tissues
  • A portable trolley and hard-shell travel case
  • The optional Patient Calm Control for added comfort

Specifications

  • Patented QMR® frequency range: 4–64 MHz
  • Power supply: 100–230V, 50/60 Hz
  • Maximum output: 20W / 200Ω dual channel
  • Medical classification: Class IIa (Directive 93/42/EEC)
  • Weight: 9 kg
  • Dimensions: 41 x 17 x 40 cm

Scientific Validation

Rexon-Eye® is supported by multiple published studies confirming both subjective symptom relief and objective improvements in tear film stability and ocular health:

  • Pedrotti et al., British Journal of Ophthalmology, 2017
  • Ferrari et al., Cornea, 2019
  • Shemer et al., Cornea, 2023
  • Ballesteros-Sánchez et al., Ophthalmology and Therapy, 2023
  • Foo et al., Frontiers in Medicine, 2023 ...and more.
Videos
Video file
Media Gallery
Image
Rexon-Eye® | A New Era in Dry Eye Therapy
Image
Rexon-Eye® | A New Era in Dry Eye Therapy
Image
Rexon-Eye® | A New Era in Dry Eye Therapy
Available Downloads
Document
5 Steps QMR.pdf528.35 KB
Document
Patient_Brochure_ENG_web.pdf246.08 KB
Document
Scientific_Book_low.pdf23.79 MB